HIGHLIGHTS
- who: Maryam Shakiba from the Cardiovascular Diseases Research Center, Guilan University have published the research: Protective effect of intensive glucose lowering therapy on all-cause mortality, adjusted for treatment switching using G-estimation method, the ACCORD trial, in the Journal: Scientific Reports Scientific Reports
- what: The authors estimated the effect of time-varying intensive glucose lowering therapy vs. standard therapy among type 2 diabetic patients on cardiovascular and all-cause mortality outcomes using the G-estimation and compared it with conventional regression model. The former approach aims to preserve the original randomization and the latter . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.